FDA approves UroGen’s muscle-invasive bladder cancer therapy
HQ Team June 13, 2025: UroGen Pharma Ltd.’s therapy to treat adult patients with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer has been
HQ Team June 13, 2025: UroGen Pharma Ltd.’s therapy to treat adult patients with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer has been
HQ Team June 12, 2025: Germany’s BioNTech SE will acquire CureVac N.V., which develops therapies based on messenger RNA, for $1.25 billion in
HQ Team June 12, 2025: Scientists are embarking on a journey to build a plant that yields nutritious food, survives heatwaves and leaves
HQ Team June 12, 2025: A machine developed by US-based HistoSonics Inc. to treat patients with primary and secondary liver tumours and other
HQ Team June 12, 2025: Novavax Inc.’s investigational vaccine that protects against both Covid-19 and seasonal flu in a single shot has generated
HQ Team June 11, 2025: The US Food and Drug Administration has approved Nuvation Bio Inc.’s medicine for adults who have a rare
HQ Team June 11, 2025: Ocean acidification, a process by which the world’s oceans absorb excess carbon dioxide from the atmosphere, becoming more